Product NDC: | 51672-1302 |
Proprietary Name: | Terconazole |
Non Proprietary Name: | Terconazole |
Active Ingredient(s): | 8 mg/g & nbsp; Terconazole |
Administration Route(s): | VAGINAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1302 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075953 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040406 |
Package NDC: | 51672-1302-0 |
Package Description: | 1 TUBE, WITH APPLICATOR in 1 CARTON (51672-1302-0) > 20 g in 1 TUBE, WITH APPLICATOR |
NDC Code | 51672-1302-0 |
Proprietary Name | Terconazole |
Package Description | 1 TUBE, WITH APPLICATOR in 1 CARTON (51672-1302-0) > 20 g in 1 TUBE, WITH APPLICATOR |
Product NDC | 51672-1302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terconazole |
Dosage Form Name | CREAM |
Route Name | VAGINAL |
Start Marketing Date | 20040406 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | TERCONAZOLE |
Strength Number | 8 |
Strength Unit | mg/g |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |